%PDF-1.4
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
uuid:29ab24e9-7932-014b-9e09-253f1bc042bf
adobe:docid:indd:24632813-a640-11e5-9294-f7950737992f
xmp.id:B8F4B616232068118DBBFBE0024743CF
proof:pdf
xmp.iid:21DB1FCD24206811822AAA8D65C7B6E8
xmp.did:CD910B7D11206811822ABF5917DAB9A5
adobe:docid:indd:24632813-a640-11e5-9294-f7950737992f
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CS6 (Macintosh)
/
2017-09-14T16:26:37+08:00
2017-09-14T16:26:37+08:00
2017-09-14T16:26:38+08:00
2017-09-14T16:26:38+08:00
Adobe InDesign CS6 (Macintosh)
application/pdf
Adobe PDF Library 10.0.1
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
11 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/Properties<>/XObject<>>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/Properties<>/XObject<>>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
14 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/Properties<>/XObject<>>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
16 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[6.0 6.0 528.0 752.95]/Type/Page>>
endobj
97 0 obj
<>stream
q
/GS0 gs
/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
10 0 0 10 59.5 30.13 Tm
(202)Tj
0.013 Tc 0.3 Tw 8.5 0 0 8.5 78 692.303 Tm
[(in strok)9.5(e patients with lar)17.6(ge v)14.7(essel intracranial)13( )]TJ
0.005 Tc -0.005 Tw 0 -1.176 TD
(occlusion. )Tj
/T1_1 1 Tf
4.438 0 Td
[(Str)44.9(ok)9.7(e)]TJ
/T1_0 1 Tf
0.05 Tw ( 2010; 41:2316-22.)Tj
0.028 Tw /Span<>> BDC
-6.556 -1.176 Td
( )Tj
EMC
0.652 0 Td
(5. )Tj
/Span<>> BDC
1.065 0 Td
( )Tj
EMC
0.401 0 Td
[(Lee KY)128.9(, Latour LL, Luby M, Hsia )54.6(A)89.8(W)91.8(, Merino JG,)5( )]TJ
0.159 Tw T*
[(W)79.8(arach S. Distal h)4.9(yperintense v)14.9(essels on FLAIR:)5( )]TJ
0.186 Tw T*
[(an MRI mark)9.8(er for collateral circulation in acute)5.1( )]TJ
-0.005 Tw T*
[(strok)9.8(e? )]TJ
/T1_1 1 Tf
3.218 0 Td
[(Neur)45(olo)]TJ
/T1_0 1 Tf
0.05 Tw (gy 2009; 72:1134-9.)Tj
-0.026 Tw /Span<>> BDC
-5.336 -1.176 Td
( )Tj
EMC
0.652 0 Td
(6. )Tj
/Span<>> BDC
1.065 0 Td
( )Tj
EMC
0.401 0 Td
[(Sanossian N, Sa)19.8(v)14.9(er JL, )55.1(Alger JR, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
-0.081 Tw [(. Angiograph)4.8(y)5.1( )]TJ
0.024 Tc 0.3 Tw T*
[(re)25.1(v)15.1(eals that \037uid-attenuated in)40(v)15.1(ersion reco)15.1(v)15.1(ery)24( )]TJ
0.005 Tc 0.121 Tw T*
[(v)24.9(ascular h)4.8(yperintensities are due to slo)24.9(w \037o)24.9(w)65(, not)5.1( )]TJ
-0.005 Tw 0 -1.176 TD
[(thromb)19.8(us. )]TJ
/T1_1 1 Tf
0.024 Tw 4.332 0 Td
[(AJNR )17.5(Am J Neur)45(or)14.9(adiol )]TJ
/T1_0 1 Tf
(2009; 30:564-8.)Tj
0.102 Tw /Span<>> BDC
-6.45 -1.176 Td
( )Tj
EMC
0.652 0 Td
(7. )Tj
/Span<>> BDC
1.065 0 Td
( )Tj
EMC
0.401 0 Td
[(Adams H, )55.3(Adams R, Del Zoppo G, Goldstein LB;)5.1( )]TJ
0.064 Tw 0 -1.176 TD
[(Strok)9.8(e Council of the )55.1(American Heart )55.1(Association;)5( )]TJ
0.268 Tw T*
[(American Strok)9.7(e )55.4(Association. Guidelines for the)5.1( )]TJ
0.026 Tw T*
[(early management of patients with ischemic strok)9.7(e:)5.1( )]TJ
-0.001 Tc -0.075 Tw T*
[(2005 guidelines update a scienti\036c statement from the)-0.9( )]TJ
0.005 Tc 0.064 Tw T*
[(Strok)9.8(e Council of the )55.1(American Heart )55.1(Association/)]TJ
-0.008 Tc -0.139 Tw T*
[(Am)0.5(eri)0.5(can)0.5( )-54.4(Str)0.5(ok)10.2(e )0.6(Ass)0.5(ocia)0.5(tio)0.5(n. )]TJ
/T1_1 1 Tf
0.008 Tw 11.714 0 Td
[(St)0.5(r)45.3(ok)10.2(e)]TJ
/T1_0 1 Tf
-0.085 Tw 2.45 0 Td
[( 20)0.5(05; 36:91)0.5(6-2)0.5(3.)]TJ
0.005 Tc 0.005 Tw /Span<>> BDC
-16.282 -1.176 Td
( )Tj
EMC
0.652 0 Td
(8.)Tj
/Span<>> BDC
( )Tj
EMC
1.466 0 Td
[(Aziyan )55.4(A, )0.5(Sanossian )0.5(N, )0.5(Mogebsen )0.5(MA, )0.5(Liebeskind)5( )]TJ
0.006 Tc 0.3 Tw T*
[(DS. Fluid-attenuated in)39.9(v)15.1(ersion reco)15(v)15.1(ery v)25.1(ascular)6( )]TJ
0.005 Tc 0.161 Tw T*
[(h)4.9(yperintensities: an important imaging mark)9.8(er for)5( )]TJ
0.224 Tw T*
[(cerebro)14.9(v)24.9(ascular disease. )]TJ
/T1_1 1 Tf
[(AJNR )17.8(Am J Neur)45(or)14.9(adiol)]TJ
/T1_0 1 Tf
0 Tc 0 Tw 21 0 Td
( )Tj
0.005 Tc 0.05 Tw -21 -1.176 Td
(2011; 32:1771-5.)Tj
-0.073 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.652 0 Td
(9.)Tj
/Span<>> BDC
( )Tj
EMC
1.466 0 Td
[(Cosnard G, Duprez )18.1(T)74(, Grandin C, )]TJ
-0.128 Tw (Smith AM)Tj
-0.005 Tw (, )Tj
18.031 0 Td
[(Munier)5.1( )]TJ
0 Tc 0 Tw -18.031 -1.176 Td
(T)Tj
0.005 Tc -0.005 Tw 0.542 0 Td
(, )Tj
0.144 Tw 0.709 0 Td
(Peeters A)Tj
0.199 Tw [(. F)14.9(ast )0.5(FLAIR sequence for detecting)5( )]TJ
0.041 Tw -1.251 -1.176 Td
[(major v)25(ascular abnormalities during the h)4.9(yperacute)5.1( )]TJ
-0.063 Tw T*
[(phase of strok)9.8(e: a comparison with MR angiograph)4.9(y)64.9(.)5( )]TJ
/T1_1 1 Tf
-0.005 Tw 0 -1.176 TD
[(Neur)45(or)14.9(adiolo)9.8(gy)]TJ
/T1_0 1 Tf
0.05 Tw ( 1999; 41:342-6.)Tj
0.055 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(10.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Kamran S, Bates )49.8(V)128.9(, Bakshi R, )29.8(Wright P)110.8(, Kink)9.7(el )29.8(W)91.9(,)5( )]TJ
0.3 Tw 0 -1.176 TD
[(Miletich R. Signi\036cance of h)4.6(yperintense v)14.6(essels)5( )]TJ
0.176 Tw T*
[(on FLAIR MRI in acute strok)9.8(e. )]TJ
/T1_1 1 Tf
-0.005 Tw [(Neur)44.9(olo)9.8(gy)]TJ
/T1_0 1 Tf
0.176 Tw [( 2000;)5( )]TJ
-0.005 Tw T*
(55:265-9.)Tj
0.245 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(11.)Tj
/Span<>> BDC
( )Tj
EMC
1.971 0 Td
[(Karadeli HH, Giur)17.9(giutiu D)39.8(V)128.9(, Colonnan L, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
0 Tc 0 Tw (. )Tj
0.005 Tc 0.283 Tw T*
[(FLAIR v)24.9(ascular h)4.9(yperintensity is a surrog)4.9(ate of)5.1( )]TJ
0.235 Tw T*
[(collateral \037o)24.9(w and leuk)9.7(oaraiosis in patients with)5( )]TJ
0.254 Tw T*
[(acute strok)9.7(e due to proximal artery occlusion. )]TJ
/T1_1 1 Tf
0 Tc 0 Tw (J )Tj
0.005 Tc -0.005 Tw T*
[(Neur)45(oima)9.8(ging)]TJ
/T1_0 1 Tf
0.05 Tw ( 2016; 26:219-23.)Tj
0.079 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(12. )Tj
/Span<>> BDC
1.57 0 Td
( )Tj
EMC
0.401 0 Td
[(Le)14.9(grand L, )18(T)34.9(isserand M, )18(T)44.9(urc G, )]TJ
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
[(. Do FLAIR)5( )]TJ
0.016 Tc 0.3 Tw T*
[(v)24.6(ascular h)4.6(yperintensity be)14.6(yond the D)29.5(WI lesion)16( )]TJ
0.018 Tc T*
(represent the ischemic penumbra? )Tj
/T1_1 1 Tf
0.282 Tw [(AJNR Am )-17.6(J)18( )]TJ
0.005 Tc -0.005 Tw T*
[(Neur)45(or)14.9(adiol)]TJ
/T1_0 1 Tf
0.05 Tw ( 2015; 36:269-74.)Tj
0.014 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(13. )Tj
/Span<>> BDC
1.57 0 Td
( )Tj
EMC
0.401 0 Td
[(Cheng B, Ebinger M, K)14.9(ufner )55.1(A, )]TJ
/T1_1 1 Tf
(et al.)Tj
/T1_0 1 Tf
[( Hyperintense)5( )]TJ
0.184 Tw T*
[(v)14.9(essels on acute strok)9.7(e Fluid-attenuated in)39.8(v)14.9(ersion)5( )]TJ
0.298 Tw T*
[(reco)14.9(v)14.8(ery imaging: associations with clinical and)5( )]TJ
0.05 Tw 0 -1.176 TD
(other MRI \036ndings. )Tj
/T1_1 1 Tf
-0.005 Tw [(Str)44.9(ok)9.8(e)]TJ
/T1_0 1 Tf
0.05 Tw ( 2012; 43:2957-61.)Tj
-0.067 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
(14. )Tj
/Span<>> BDC
1.57 0 Td
( )Tj
EMC
0.401 0 Td
(Olindo S, Chausson N, Joux J, )Tj
/T1_1 1 Tf
(et al)Tj
/T1_0 1 Tf
[(. Fluid-attenuated)5.1( )]TJ
0.023 Tw 0 -1.176 TD
[(in)39.8(v)14.9(ersion reco)14.9(v)14.9(ery v)25(ascular h)4.9(yperintensity: an early)5( )]TJ
0.211 Tw T*
[(predictor of clinical outcome in proximal middle)5( )]TJ
-0.012 Tc -0.123 Tw T*
(cerebral artery occlusion. )Tj
/T1_1 1 Tf
[(Ar)37.1(c)15.2(h Neur)45.2(ol)]TJ
/T1_0 1 Tf
( 2012; 69:1462-8.)Tj
0.015 Tc 0.3 Tw /Span<>> BDC
-2.118 -1.176 Td
( )Tj
EMC
0.147 0 Td
[(1)10(5)10(.)]TJ
/Span<>> BDC
1.265 0 Td
( )Tj
EMC
0.706 0 Td
[(Schellinger PD, Chalela J)59.7(A, Kang D)29.7(W)91.7(, Latour)15( )]TJ
0.006 Tc T*
[(LL, )29.4(W)79.4(arach S. Diagnostic and prognostic v)24.4(alue)6.1( )]TJ
0.005 Tc 0.182 Tw T*
[(of early MR imaging v)14.9(essel signs in h)4.9(yper acute)5( )]TJ
0.13 Tw T*
[(strok)9.8(e patients imaged < 3 hours and treated with)5( )]TJ
-0.034 Tw T*
[(recombinant tissue plasminogen acti)24.9(v)24.9(ator)54.9(. )]TJ
/T1_1 1 Tf
-0.052 Tw [(AJNR Am)5.1( )]TJ
0.05 Tw 0 -1.353 TD
[(J Neur)44.9(or)14.9(adiol)]TJ
/T1_0 1 Tf
( 2005; 26:618-24.)Tj
ET
endstream
endobj
31 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
0 Tc -0.018 Tw 0 Ts 100 Tz 0 Tr 9.5 0 0 9.5 60 721.5115 Tm
[(Neur)45(olo)9.7(gy Asia)]TJ
0.05 Tw 36.742 0 Td
(September 2017)Tj
ET
endstream
endobj
98 0 obj
<>
endobj
99 0 obj
<>
endobj
100 0 obj
<>stream
H\n0y
CG)Qia`:@l\u"MTV3Da5
8`.xJRh{;oW%4PnT@Ai<=7*z-]髬77p@7CE-v$f@ִmՒ-E|.!]4c'X21̙Nеi*i~7A㘌2;ʉp
ZXgqLv>w+Q&crY'E3g |`.K,Lhg- gRWs]-f{VOwC聲Q C5}
endstream
endobj
101 0 obj
<>stream
HTyTSW~!$VSb]QutゃXEkHB @kdqXX@9{Վ=̙s~w00`{;ɒJ_Ud,z_Rv34' JPΞyиGU3xdudfp=%cRJ4Y)MNUS*iD=)I8R(UJjG?R)Q)"cɑDIjOʔK%wI"SbRc2=J)E*dR'q[`a0Svc>`X(-vpk~䘝L\=s|x]{Z/Dwr'`t\XO2Ը"}GĠ&"?arEچm忂ABc={؉E])+[4,clnΧWMxqcb~C.h{ц\1}.})hA0
?j-.B-zrKj쾽 EHTx :5lqg{Gq}6orގ{(x&kB
}!qkV2\Ps׃CCv7RY(.ntWAkFqqtZApIpZ+AyiU1CO'N/%Qw>/FWbqY;oh6Ģ.hQn^P@V~)l@\ejl݄9hx#^kܰ
3OQCYS#1ILl<9 aWQ9"SYAy^ǜ4Z=I{{l?\ZEgp.CJV]yesgŸ;M)W̦'9Ήo]LS0RF;vá
ac<Ȧ**^ZF_z!0^4$A94\i<|ʙߜY=9kIP4kWښ!'~TmTTukٱB#su45ZaoRSeg=u~"-d9sYjp~b?}}涰-ؽ$ZVha]0f#$`j|`F侫ΌEî&V+Ij{[S:{緄<@;oh[^jzzoC{xN|mؾ~krh\wXww=Va _hohxAd uLZAWiL-`vYYY}np?__|Nt9w7y|fbTw$Ę`0UCepaZrnci~{Xy~mvzzvafwfqv}]bV<`Ew~PG~y={[y!t}V^ns K
endstream
endobj
18 0 obj
<>
endobj
20 0 obj
<>
endobj
21 0 obj
<>
endobj
105 0 obj
<>
endobj
106 0 obj
<>stream
H\j@E^&GWW `<v$?}uCF`눮ǽEWC?gCͩ-ù2]Ο_{i,Oɇup6tx